Search research articles
Contact Us
Filters
Showing results (81-90 of 176) with videos related to
Page
of 18
Sort By:
The Lancet Regional Health. Europe
|
November 14, 2025
Estimating incidence rates of primary infection and reinfection with hepatitis C virus among people who inject drugs in Scotland: a model-based analysis of repeated cross-sectional survey data
Scott A McDonald, Norah Palmateer, Andrew McAuley, et al.
Frontline Gastroenterology
|
September 2, 2022
Identification of liver disease: why and how
Iain Macpherson, Kushala W M Abeysekera, Rebecca Harris, et al.
Journal of Viral Hepatitis
|
November 14, 2018
High response and re-infection rates among people who inject drugs treated for hepatitis C in a community needle and syringe programme
Jasmine Schulkind, Brian Stephens, Farsana Ahmad, et al.
BMJ Open
|
August 11, 2019
Randomised controlled trial conducted in injecting equipment provision sites to compare the effectiveness of different hepatitis C treatment regimens in people who inject drugs: A Direct obserVed therApy versus fortNightly CollEction study for HCV treatment-ADVANCE HCV protocol study
Sarah K Inglis, Lewis Jz Beer, Christopher Byrne, et al.
The Lancet. Gastroenterology & Hepatology
|
June 12, 2020
Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial
Andrew Radley, Marijn de Bruin, Sarah K Inglis, et al.
British Journal of Health Psychology
|
July 12, 2025
Post-treatment life-trajectories among people who inject drugs who completed hepatitis C treatment with direct acting antivirals: A thematic analysis
Gabriele Vojt, Lawrie Elliott, Hannah Family, et al.
European Journal of Gastroenterology & Hepatology
|
September 24, 2009
Hospitalization of hepatitis C-diagnosed individuals in Scotland for decompensated cirrhosis: a population-based record-linkage study
Scott A McDonald, Sharon J Hutchinson, Sheila M Bird, et al.
Alimentary Pharmacology & Therapeutics
|
December 8, 2021
Real-world outcomes of rapid regional hepatitis C virus treatment scale-up among people who inject drugs in Tayside, Scotland
Christopher J Byrne, Lewis Beer, Sarah K Inglis, et al.
Journal of Hepatology
|
February 11, 2014
Patient-important benefits of clearing the hepatitis C virus through treatment: a simulation model
Hamish Innes, David Goldberg, Geoffrey Dusheiko, et al.
BMJ Open Gastroenterology
|
March 23, 2022
Predicting 1-year mortality among patients with decompensated cirrhosis: results of a multicentre evaluation of the Bristol Prognostic Score
Sarah Pauline Bowers, Kathleen Clare, Louise Hagerty, et al.
Page
of 18
Search research articles
Search
Showing results (81-90 of 176) with videos related to
Sort By:
Page
of 18
The Lancet Regional Health. Europe
|
November 14, 2025
Estimating incidence rates of primary infection and reinfection with hepatitis C virus among people who inject drugs in Scotland: a model-based analysis of repeated cross-sectional survey data
Scott A McDonald, Norah Palmateer, Andrew McAuley, et al.
Frontline Gastroenterology
|
September 2, 2022
Identification of liver disease: why and how
Iain Macpherson, Kushala W M Abeysekera, Rebecca Harris, et al.
Journal of Viral Hepatitis
|
November 14, 2018
High response and re-infection rates among people who inject drugs treated for hepatitis C in a community needle and syringe programme
Jasmine Schulkind, Brian Stephens, Farsana Ahmad, et al.
BMJ Open
|
August 11, 2019
Randomised controlled trial conducted in injecting equipment provision sites to compare the effectiveness of different hepatitis C treatment regimens in people who inject drugs: A Direct obserVed therApy versus fortNightly CollEction study for HCV treatment-ADVANCE HCV protocol study
Sarah K Inglis, Lewis Jz Beer, Christopher Byrne, et al.
The Lancet. Gastroenterology & Hepatology
|
June 12, 2020
Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial
Andrew Radley, Marijn de Bruin, Sarah K Inglis, et al.
British Journal of Health Psychology
|
July 12, 2025
Post-treatment life-trajectories among people who inject drugs who completed hepatitis C treatment with direct acting antivirals: A thematic analysis
Gabriele Vojt, Lawrie Elliott, Hannah Family, et al.
European Journal of Gastroenterology & Hepatology
|
September 24, 2009
Hospitalization of hepatitis C-diagnosed individuals in Scotland for decompensated cirrhosis: a population-based record-linkage study
Scott A McDonald, Sharon J Hutchinson, Sheila M Bird, et al.
Alimentary Pharmacology & Therapeutics
|
December 8, 2021
Real-world outcomes of rapid regional hepatitis C virus treatment scale-up among people who inject drugs in Tayside, Scotland
Christopher J Byrne, Lewis Beer, Sarah K Inglis, et al.
Journal of Hepatology
|
February 11, 2014
Patient-important benefits of clearing the hepatitis C virus through treatment: a simulation model
Hamish Innes, David Goldberg, Geoffrey Dusheiko, et al.
BMJ Open Gastroenterology
|
March 23, 2022
Predicting 1-year mortality among patients with decompensated cirrhosis: results of a multicentre evaluation of the Bristol Prognostic Score
Sarah Pauline Bowers, Kathleen Clare, Louise Hagerty, et al.
Page
of 18